Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: A prospective institutional study

Journal of Urology

Volumn 173, Issue 2, 2005, Pages 425-428

  Gjengstø, Peder ^a   Paus, Elisabeth ^c   Halvorsen, Ole Johan ^b   Eide, Johan ^b   Akslen, Lars Andreas ^b   Wentzel Larsen, Tore ^a   Hoisaeter, Per Aage ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biological; Prostate; Prostate specific antigen; Prostatic neoplasms; Tumor markers

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; CONTROLLED STUDY; HUMAN; LOGISTIC REGRESSION ANALYSIS; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; TUMOR BIOPSY; ULTRASOUND;

EID: 12544252616     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000149805.83040.1f     Document Type: Article

References (19)

1. Lilja, H.: Regulation of the enzymatic activity of protease-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer. Scand J Clin Lab Invest Suppl, 220: 47, 1995
2. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C. et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol, 151: 1283, 1994
3. Roehl, A. K., Antenor, J. A. V. and Catalona, W. J.: Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range. J Urol, 168: 922, 2002
4. Zlotta, A. R., Djavan, B., Marberger, M. and Schulman, C. C.: Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol, 157: 1315, 1997
5. Kikuchi, E., Nakashima, J., Ishibashi, M., Ohigashi, T., Asakur, H., Tachibana, M. et al: Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma. Cancer, 89: 842, 2000
6. Jiang, Y., Metz, C. E. and Nishikawa, R. M.: A receiver operating characteristic partial area index for highly sensitive diagnostic tests. Radiology, 201: 745, 1996
7. Huo, Z., Giger, M. L., Vyborny, C. J. and Metz, C. E.: Breast cancer: effectiveness of computer-aided diagnosis observer study with independent database of mammograms. Radiology, 224: 560, 2002
8. Shinohara, K.: Transrectal ultrasonography in the evaluation of benign prostatic hyperplasia. In: Benign Prostatic Hyperplasia. Edited by P. Narayan. London: Churchill Livingstone, pp. 125-137, 2000
9. A Language and Environment for Statistical Computing. R Development Core Team. Vienna: R Foundation for Statistical Computing, 2003. Available at http://www.r-project.org. Accessed December 18, 2003
10. Stamey, T. A. and Yemoto, C. E.: Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume. J Urol, 163: 119, 2000
11. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A. et al: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol, 147: 815, 1992
12. Djavan, B., Remzi, M., Zlotta, A. R., Ravery, V., Hammerer, P., Reissigl, A. et al: Complexed prostate-specific antigen, complexed prostate specific-antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial. Urology, suppl., 60: 4, 2002
13. Djavan, B., Zlotta, A., Remzi, M., Ghawidel, K., Basharkhah, A., Schulman, C. C. et al: Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol, 163: 1144, 2000
14. Brawer, M. K.: Prostate specific antigen some observations. Edited by D. Kirk. In: International Handbook of Prostate Cancer. Surrey, United Kingdom: Euromed Communications, Ltd., p. 43, 2002
15. Sech, S., Montoya, J., Girman, C. J., Rhodes, T. and Roehrborn, C. G.: Interexaminer reliability of transrectal ultrasound for estimating prostate volume. J Urol, 166: 125, 2001
16. Zackrisson, B., Aus, G., Lilja, H., Lodding, P., Pihl, C. G. and Hugosson, J.: Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Eur Urol, 43: 327, 2003
17. Khan, M. A., Partin, A. W., Rittenhouse, H. G., Mikolajczyk, S. D., Sokoll, L. J., Chan, D. W. et al: Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml. J Urol, 170: 723, 2003
18. Sokoll, L. J., Chan, D. W., Mikolajczyk, S. D., Rittenhouse, H. G., Evans, C. L., Linton, H. J. et al: Proenzyme psa for early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis. Urology, 61: 274, 2003
19. van Erkel, A. R. and Pattynama, P. M. T.: Receiver operating characteristic (ROC) analysis: basic principles and applications in radiology. Eur J Radiol, 27: 88, 1998